Mona M Khamis1, Teagan Holt1, Hanan Awad2, Anas El-Aneed1, Darryl J Adamko3. 1. College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada. 2. Calgary Laboratory Services, Alberta Health Services, Calgary, AB, Canada. 3. Department of Pediatrics, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada. darryl.adamko@usask.ca.
Abstract
INTRODUCTION: Urine is an ideal matrix for metabolomics investigation due to its non-invasive nature of collection and its rich metabolite content. Despite the advancements in mass spectrometry and 1H-NMR platforms in urine metabolomics, the statistical analysis of the generated data is challenged with the need to adjust for the hydration status of the person. Normalization to creatinine or osmolality values are the most adopted strategies, however, each technique has its challenges that can hinder its wider application. We have been developing targeted urine metabolomic methods to differentiate two important respiratory diseases, namely asthma and chronic obstructive pulmonary disease (COPD). OBJECTIVE: To assess whether the statistical model of separation of diseases using targeted metabolomic data would be improved by normalization to osmolality instead of creatinine. METHODS: The concentration of 32 metabolites was previously measured by two liquid chromatography-tandem mass spectrometry methods in 51 human urine samples with either asthma (n = 25) or COPD (n = 26). The data was normalized to creatinine or osmolality. Statistical analysis of the normalized values in each disease was performed using partial least square discriminant analysis (PLS-DA). Models of separation of diseases were compared. RESULTS: We found that normalization to creatinine or osmolality did not significantly change the PLS-DA models of separation (R2Q2 = 0.919, 0.705 vs R2Q2 = 0.929, 0.671, respectively). The metabolites of importance in the models remained similar for both normalization methods. CONCLUSION: Our findings suggest that targeted urine metabolomic data can be normalized for hydration using creatinine or osmolality with no significant impact on the diagnostic accuracy of the model.
INTRODUCTION: Urine is an ideal matrix for metabolomics investigation due to its non-invasive nature of collection and its rich metabolite content. Despite the advancements in mass spectrometry and 1H-NMR platforms in urine metabolomics, the statistical analysis of the generated data is challenged with the need to adjust for the hydration status of the person. Normalization to creatinine or osmolality values are the most adopted strategies, however, each technique has its challenges that can hinder its wider application. We have been developing targeted urine metabolomic methods to differentiate two important respiratory diseases, namely asthma and chronic obstructive pulmonary disease (COPD). OBJECTIVE: To assess whether the statistical model of separation of diseases using targeted metabolomic data would be improved by normalization to osmolality instead of creatinine. METHODS: The concentration of 32 metabolites was previously measured by two liquid chromatography-tandem mass spectrometry methods in 51 human urine samples with either asthma (n = 25) or COPD (n = 26). The data was normalized to creatinine or osmolality. Statistical analysis of the normalized values in each disease was performed using partial least square discriminant analysis (PLS-DA). Models of separation of diseases were compared. RESULTS: We found that normalization to creatinine or osmolality did not significantly change the PLS-DA models of separation (R2Q2 = 0.919, 0.705 vs R2Q2 = 0.929, 0.671, respectively). The metabolites of importance in the models remained similar for both normalization methods. CONCLUSION: Our findings suggest that targeted urine metabolomic data can be normalized for hydration using creatinine or osmolality with no significant impact on the diagnostic accuracy of the model.
Authors: Carolyn M Slupsky; Kathryn N Rankin; James Wagner; Hao Fu; David Chang; Aalim M Weljie; Erik J Saude; Bruce Lix; Darryl J Adamko; Sirish Shah; Russ Greiner; Brian D Sykes; Thomas J Marrie Journal: Anal Chem Date: 2007-08-17 Impact factor: 6.986
Authors: Franziska C Vogl; Sebastian Mehrl; Leonhard Heizinger; Inga Schlecht; Helena U Zacharias; Lisa Ellmann; Nadine Nürnberger; Wolfram Gronwald; Michael F Leitzmann; Jerome Rossert; Kai-Uwe Eckardt; Katja Dettmer; Peter J Oefner Journal: Anal Bioanal Chem Date: 2016-11-04 Impact factor: 4.142
Authors: Cherith N Reid; Michael Stevenson; Funso Abogunrin; Mark W Ruddock; Frank Emmert-Streib; John V Lamont; Kate E Williamson Journal: PLoS One Date: 2012-12-31 Impact factor: 3.240
Authors: Karien Esterhuizen; J Zander Lindeque; Shayne Mason; Francois H van der Westhuizen; Richard J Rodenburg; Paul de Laat; Jan A M Smeitink; Mirian C H Janssen; Roan Louw Journal: Metabolomics Date: 2021-01-12 Impact factor: 4.290
Authors: Charles J Blijdorp; Omar A Z Tutakhel; Thomas A Hartjes; Thierry P P van den Bosch; Martijn H van Heugten; Juan Pablo Rigalli; Rob Willemsen; Usha M Musterd-Bhaggoe; Eric R Barros; Roger Carles-Fontana; Cristian A Carvajal; Onno J Arntz; Fons A J van de Loo; Guido Jenster; Marian C Clahsen-van Groningen; Cathy A Cuevas; David Severs; Robert A Fenton; Martin E van Royen; Joost G J Hoenderop; René J M Bindels; Ewout J Hoorn Journal: J Am Soc Nephrol Date: 2021-03-29 Impact factor: 10.121
Authors: Uta Erdbrügger; Charles J Blijdorp; Irene V Bijnsdorp; Francesc E Borràs; Dylan Burger; Benedetta Bussolati; James Brian Byrd; Aled Clayton; James W Dear; Juan M Falcón-Pérez; Cristina Grange; Andrew F Hill; Harry Holthöfer; Ewout J Hoorn; Guido Jenster; Connie R Jimenez; Kerstin Junker; John Klein; Mark A Knepper; Erik H Koritzinsky; James M Luther; Metka Lenassi; Janne Leivo; Inge Mertens; Luca Musante; Eline Oeyen; Maija Puhka; Martin E van Royen; Catherine Sánchez; Carolina Soekmadji; Visith Thongboonkerd; Volkert van Steijn; Gerald Verhaegh; Jason P Webber; Kenneth Witwer; Peter S T Yuen; Lei Zheng; Alicia Llorente; Elena S Martens-Uzunova Journal: J Extracell Vesicles Date: 2021-05-21
Authors: Robert M Moldwin; Vishaan Nursey; Oksana Yaskiv; Siddhartha Dalvi; Eric J Macdonald; Michael Funaro; Chengliang Zhang; William DeGouveia; Marina Ruzimovsky; Horacio R Rilo; Edmund J Miller; Souhel Najjar; Inna Tabansky; Joel N H Stern Journal: J Transl Med Date: 2022-02-21 Impact factor: 5.531
Authors: Julia Jacyna; Marta Kordalewska; Małgorzata Artymowicz; Marcin Markuszewski; Marcin Matuszewski; Michał J Markuszewski Journal: Cancers (Basel) Date: 2022-02-25 Impact factor: 6.639
Authors: Selinay Ozdemir; Clara G Sears; James M Harrington; Aslak Harbo Poulsen; Jessie Buckley; Chanelle J Howe; Katherine A James; Anne Tjonneland; Gregory A Wellenius; Ole Raaschou-Nielsen; Jaymie Meliker Journal: Toxics Date: 2021-11-01
Authors: Ana K Rosen Vollmar; Nicholas J W Rattray; Yuping Cai; Álvaro J Santos-Neto; Nicole C Deziel; Anne Marie Z Jukic; Caroline H Johnson Journal: Metabolites Date: 2019-09-21